Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Business
  • Real Estate
  • Technology
  • Health
  • Non-profit
ncarol.com

OCI Announces Appointment of Dr. Luke Matranga, Former President of Academy of General Dentistry, to OCI Dental Advisory Board
ncarol.com/10060838

Trending...
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 123
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 115
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 114
Dr Luke Matranga Oral Cancer Initiative, LLC
CHICAGO - ncarol.com -- Dr. Matranga earned his DDS at Marquette University School of Dentistry in 1966. After joining the U S. Air Force, Captain Matranga served as a General Dental Officer at several Air Force bases, including Phan Rang Air Base, Viet Nam, and San Vito, Air Station, Italy, as Preventative Dental Officer. At Phan Rang Air Base, he served as Chief Dental Officer on the Medical Civil Action Team. Captain Matranga earned his MS degree in General Dentistry from the University of Texas at Houston in 1973, and his Board Certification in 1976.

During his twenty-two-year military career, he served as Base Dental Surgeon at Anderson Air Force Base Guam, and Chanute Air Force Base, Illinois. Colonel Matranga also served as Director of three General Residency Programs. Colonel Matranga served as Command General Surgeon at Offutt Air Force Base Nebraska, where he was responsible for the dental health of 110,000 active duty personnel, 230,000 dependents, and 500,000 Air Force retirees at twenty-five dental facilities worldwide. His distinguished Air Force career continued until he retired from the USAF in 1988.

In 1988, Dr. Matranga accepted an Associate Professorship in the Department of Fixed Prosthodontics at Creighton University. He was appointed Chair of the Department of Comprehensive Dental Care at Creighton University in 1989 and remained in that position through 2000. Dr. Matranga currently continues at Creighton as Associate Professor in the Department of General Dentistry, while also caring for patients in his private general dentistry practice in Omaha. Dr. Matranga is also licensed in the State of Florida as an Expert Witness.

More on ncarol.com
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Lake Norman Philharmonic Annual Holiday Concert 2026
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail

On accepting the Dental Advisory Board position, Dr. Matranga commented:

I am honored to have been invited to join this great organization as a member of the Dental Advisory Board.  Oral cancer remains a significant public health issue. Hopefully, I can help to educate members of the Dental Profession and the public on the signs and symptoms of this deadly disease. Through education, we can, hopefully, motivate the profession to detect problem areas early and to encourage the public to seek oral examinations on a routine and regular basis.

A FEW OF Dr. MATRANGA'S MANY ACCOMPLISHMENTS INCLUDE:
  • Former President Academy of General Dentistry
  • Former Executive Director of Nebraska Academy of General Dentistry
  • Former Member Board of Directors of Academy of General Dentistry
  • Former President Federal Services Board of General Dentistry

 PROFESSIONAL HONORS:
  • Fellow – Academy of General Dentistry
  • Fellow – American College of Dentists
  • Master – Academy of General Dentistry
  • Board Certified- American Board of General Dentistry

MILITARY AWARDS/DECORATIONS:

More on ncarol.com
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board

  • Republic of Vietnam Gallantry Cross with Palm          
  • Vietnam Service & Campaign Medals
  • Meritorious Service Medal
  • Outstanding Unit Award with "Valor" Device Air
  • Force Commendation Medal
  • Legion of Merit
  • Bronze Star

Dr. Matranga has also been a prolific contributor to professional journals, published on a myriad of subjects, from general dentistry to prosthodontics. He is also invited frequently as a Speaker and Lecturer.

OCI Co-Chair, Dr. Howard Glazer and Dr. Matranga have had a professional relationship for many years. Dr. Glazer noted:

Dr. Luke Matranga has been a strong advocate for oral health and, in particular, oral cancer. He has been a leader in the military (USAF-ret.), organized dentistry (Past President of the Academy of General Dentistry), and academia as a faculty member at Creighton University School of Dentistry. Undoubtedly, his passion for helping people will be an asset to our Advisory Board, and we look forward to his helping us save lives through the Oral Cancer Initiative.

ORAL CANCER INITIATIVE IN BRIEF:

Oral Cancer Initiative's mission is to heighten awareness of the danger of oral cancer and save lives through oral cancer screening events.

Our model is to act boldly and think big by offering large-scale free screening events to communities around the country through school districts, large corporations, and other organizations committed to the health of their communities.

Contact
Pamela Adams - Oral Cancer Initiative
VP Media & Communications
***@oralcancerinitiative.com


Source: Oral Cancer Initiative

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • 7th Annual RACE INDUSTRY WEEK Returns Nov. 30 – Dec. 3 With Free Live Webinars From Racing Leaders
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • AQUALIS of Morrisville, NC, Acquires Full Circle Environmental of Garner, NC
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parade of Homes Winners Announced - 253
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 191
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 181
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 127
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 123
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 116
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 115
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 114
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options - 113
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology - 111

Similar on ncarol.com

  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute